1 reports of this reaction
3.2% of all SALICYLIC ACID 17% WART REMOVER reports
#7 most reported adverse reaction
DECREASED INTEREST is the #7 most commonly reported adverse reaction for SALICYLIC ACID 17% WART REMOVER, manufactured by AAA Pharmaceutical, Inc.. There are 1 FDA adverse event reports linking SALICYLIC ACID 17% WART REMOVER to DECREASED INTEREST. This represents approximately 3.2% of all 31 adverse event reports for this drug.
Patients taking SALICYLIC ACID 17% WART REMOVER who experience decreased interest should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DECREASED INTEREST is moderately reported among SALICYLIC ACID 17% WART REMOVER users, representing a notable but not dominant share of adverse events.
In addition to decreased interest, the following adverse reactions have been reported for SALICYLIC ACID 17% WART REMOVER:
DECREASED INTEREST has been reported as an adverse event in 1 FDA reports for SALICYLIC ACID 17% WART REMOVER. This does not prove causation, but indicates an association observed in post-market surveillance data.
DECREASED INTEREST accounts for approximately 3.2% of all adverse event reports for SALICYLIC ACID 17% WART REMOVER, making it a notable side effect.
If you experience decreased interest while taking SALICYLIC ACID 17% WART REMOVER, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.